Sleep Duration in Mouse Models of Neurodevelopmental Disorders

Sleep Duration in Mouse Models of Neurodevelopmental Disorders

Sleep abnormalities are common in patients with neurodevelopmental disorders, and it is thought that deficits in sleep may contribute to the unfolding of symptoms in these disorders. Appreciating sleep abnormalities in neurodevelopmental disorders could be important for designing a treatment for the...

Full description

Bibliographic Details
Main Authors:	Rachel Michelle Saré, Abigail Lemons, Alex Song, Carolyn Beebe Smith
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Brain Sciences
Subjects:	neurodevelopmental disorders sleep duration Phelan–McDermid syndrome Shank3 oxytocin receptor tuberous sclerosis
Online Access:	https://www.mdpi.com/2076-3425/11/1/31

Similar Items

Dissecting the Heterogeneity of Autism: Focus on Phelan-McDermid Syndrome
by: C. Lamschtein, et al.
Published: (2022-06-01)

Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat
by: Hala Harony-Nicolas, et al.
Published: (2017-01-01)

Clinical and Genetic Aspects of Phelan–McDermid Syndrome: An Interdisciplinary Approach to Management
by: Francisco Cammarata-Scalisi, et al.
Published: (2022-03-01)

Sleep and Phelan–McDermid Syndrome: Lessons from the International Registry and the scientific literature
by: Bridgette A. Moffitt, et al.
Published: (2022-10-01)

Development of sex- and genotype-specific behavioral phenotypes in a Shank3 mouse model for neurodevelopmental disorders
by: Helen Friedericke Bauer, et al.
Published: (2023-01-01)

Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression—A Case Report
by: Sarah Jesse, et al.
Published: (2021-02-01)

Caregiver perspectives on patient-focused drug development for Phelan-McDermid syndrome
by: Luciana Gizzo, et al.
Published: (2024-03-01)

Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI
by: Sarah Jesse, et al.
Published: (2023-09-01)

Prospective One-Year Follow-Up of Sensory Processing in Phelan–McDermid Syndrome
by: Sergio Serrada-Tejeda, et al.
Published: (2023-06-01)

Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models. [version 2; peer review: 2 approved]
by: Robert A. Kozol, et al.
Published: (2023-09-01)

Bridging the translational gap: what can synaptopathies tell us about autism?
by: Ciara J. Molloy, et al.
Published: (2023-06-01)

Sensory Reactivity Phenotype in Phelan–McDermid Syndrome Is Distinct from Idiopathic ASD
by: Teresa Tavassoli, et al.
Published: (2021-06-01)

Efficacity of tDCS in catatonic patients with Phelan McDermid syndrome, a case series
by: Mylène Moyal, et al.
Published: (2022-11-01)

Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
by: Sarah Jesse, et al.
Published: (2023-03-01)

Síndrome de Phelan-McDermid: reporte de un caso y revisión de la literatura
by: Mariana Hernández Gómez, et al.
Published: (2018-01-01)

Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism
by: Anastasia Neklyudova, et al.
Published: (2022-04-01)

Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
by: Brianna Dyar, et al.
Published: (2021-07-01)

Social behavioral impairments in SYNGAP1-related intellectual disability
by: Hajer Naveed, et al.
Published: (2023-11-01)

Pervasive developmental disorders with a complex structure (epileptic seizures, catatonic, hallucinatory and manic symptoms, delirious episodes during life)
by: H. Makarenko
Published: (2022-06-01)

Altered Intestinal Morphology and Microbiota Composition in the Autism Spectrum Disorders Associated SHANK3 Mouse Model
by: Ann Katrin Sauer, et al.
Published: (2019-04-01)

Sensory Processing Phenotypes in Phelan-McDermid Syndrome and <i>SYNGAP1</i>-Related Intellectual Disability
by: Ariel M. Lyons-Warren, et al.
Published: (2022-01-01)

Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors
by: Luigi Boccuto, et al.
Published: (2022-03-01)

Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
by: Bridgette A. Moffitt, et al.
Published: (2023-02-01)

Early-onset catatonia associated with SHANK3 mutations: looking at the autism spectrum through the prism of psychomotor phenomena
by: Dirk Dhossche, et al.
Published: (2023-09-01)

Prenatal and postnatal diagnosis of Phelan–McDermid syndrome: A report of 21 cases from a medical center and review of the literature
by: Ying Hao, et al.
Published: (2022-08-01)

Brain Gene Co-Expression Network Analysis Identifies 22q13 Region Genes Associated with Autism, Intellectual Disability, Seizures, Language Impairment, and Hypotonia
by: Snehal Shah, et al.
Published: (2023-10-01)

State of the Science for Kidney Disorders in Phelan-McDermid Syndrome: UPK3A, FBLN1, WNT7B, and CELSR1 as Candidate Genes
by: Megan D. McCoy, et al.
Published: (2022-06-01)

Hyperbaric Oxygen Therapy Alleviates Social Behavior Dysfunction and Neuroinflammation in a Mouse Model for Autism Spectrum Disorders
by: Inbar Fischer, et al.
Published: (2022-09-01)

Head Size in Phelan–McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13
by: Sara M. Sarasua, et al.
Published: (2023-02-01)

Relación entre el tamaño de deleción y afectación del lenguaje en síndrome de Phelan-McDermid: revisión sistemática
by: Miriam Vicente-Martínez, et al.
Published: (2021-12-01)

Molecular cytogenetic and phenotypic characterization of Phelan McDermid and 22q13 duplication syndrome: a case report
by: Yousif Khalifa, et al.
Published: (2022-12-01)

Sleep Abnormalities in the Synaptopathies—<i>SYNGAP1</i>-Related Intellectual Disability and Phelan–McDermid Syndrome
by: Constance Smith-Hicks, et al.
Published: (2021-09-01)

A 9-year-old-girl with Phelan McDermid Syndrome, who had been diagnosed with an autism spectrum disorder
by: Görker I, et al.
Published: (2016-12-01)

“Your Life Turns Upside Down”: A Qualitative Study of the Experiences of Parents with Children Diagnosed with Phelan-McDermid Syndrome
by: Cristina García-Bravo, et al.
Published: (2022-12-01)

Identification of a Novel <i>SHANK2</i> Pathogenic Variant in a Patient with a Neurodevelopmental Disorder
by: Gabriella Doddato, et al.
Published: (2022-04-01)

Shank3 modulates sleep and expression of circadian transcription factors
by: Ashley M Ingiosi, et al.
Published: (2019-04-01)

Sleep duration and perceptions of sleep quality in British Army recruits during basic training - an observational analysis
by: Alex J. Rawcliffe, et al.
Published: (2024-02-01)

Sleep habits as an indicator of social competence and behaviour in pre-schoolers in the context of neurodevelopmental disorders
by: Tayfun Kara, et al.
Published: (2019-01-01)

Association of sleep quality and duration with gestational diabetes mellitus: The Qazvin maternal and neonatal metabolic study
by: Sima Hashemipour, et al.
Published: (2022-01-01)

Subjective sleep quality and sleep duration of patients in a psychiatric hospital
by: Matthias J. Müller, et al.
Published: (2016-07-01)